articles Ratings /ratings/en/research/articles/200214-amid-coronavirus-outbreak-s-p-global-ratings-looks-at-how-a-hypothetical-pandemic-could-affect-u-s-life-insu-11349717 content esgSubNav
In This List
COMMENTS

Amid Coronavirus Outbreak, S&P Global Ratings Looks At How A Hypothetical Pandemic Could Affect U.S. Life Insurers

COMMENTS

Cyber Insurance At The Crossroads

COMMENTS

Credit FAQ: How We Reflect Risk Transfer Solutions In Insurance Ratings

COMMENTS

Credit FAQ: Key Risks In South African Insurance

COMMENTS

Thai Insurance Brief: Myanmar Earthquake Hit Will Be Absorbed By Reinsurers


Amid Coronavirus Outbreak, S&P Global Ratings Looks At How A Hypothetical Pandemic Could Affect U.S. Life Insurers

As of this writing, the new coronavirus (COVID-19) has led to more deaths in China than the 2002-2003 SARS outbreak in the country. The virus is currently considered an epidemic, with majority of the related mortality concentrated in a single region. But, concerning signs--such as human-to-human transmission and more reported cases outside China--indicate the possibility of a wider geographic spread of the disease.

For the purpose of assessing economic and credit implications of the outbreak, S&P Global Ratings assumes the outbreak will be contained by March, consistent with our recent report (see "Coronavirus To Inflict A Large, Temporary Blow To China's Economy," published Feb. 6, 2020). As the situation develops, we will update our assumptions and estimates accordingly.

The current spread of COVID-19 has no reported deaths in the U.S. and, at current levels of mortality, we expect limited to no impact on U.S. life insurers that are holding about $20 trillion of net inforce life insurance on their balance sheets. But, what could the impact of a global pandemic or an extreme mortality event be on U.S. life insurers? We undertook hypothetical (unrelated to COVID-19) extreme and moderate mortality stress tests to ascertain that potential effect on life insurers.

We estimate that an extreme pandemic event (based on the 1918 "Spanish flu" event) would result in about $52 billion of excess net mortality claims (aftertax), about 12% of the aggregate U.S. life insurance industry capital. It is important to note that this hypothetical extreme scenario is a very low-probability and high-severity event. We do not assume this scenario in our base-case insurer or sector expectations.

Our moderate pandemic event stress (based on the 1957 "Asian flu" pandemic) showed $7 billion of additional excess net mortality claims (aftertax). This represents about 2% of outstanding industry capital, and would have a limited impact on the industry's financial strength.

We view the capitalization levels for rated U.S. life insurers as strong. Our capital analysis indicates that rated U.S. life insurers have slightly above 10% capital redundancy, in aggregate, at the 'AA' level. Comparing that capital redundancy with the 12% extreme stressed impact, we expect a decline in the capitalization levels, and potential effect on credit quality of some insurers. On the other hand, a 2% effect from the moderate scenario is very manageable considering insurers' overall financial strength.

Chart 1

image

Stress Test: Extreme And Moderate Mortality Scenarios

There were four key steps for our mortality stress test.

The first step was to identify historical pandemic events and quantify the additional deaths based on such events (referred to as excess deaths per 1,000).

Second, we translated the excess deaths in the general population to excess insured deaths. We assume the impact would be less on the insured population. Not everyone has a life insurance policy, and socioeconomic demographics of the insured population can differ from the aggregate population.

Third, we estimated the amount of excess claims that could result from the excess insured deaths for each stress scenario.

And finally, we used the current corporate tax rate to calculate the posttax excess claims and their impact on life insurers.

Table 1

Mortality Stress Scenario Details
Pandemics used for stress scenarios Assumed general population excess deaths per 1,000* Insured-to-general population mortality ratio (%) Insured deaths per 1,000 (population deaths* to insured-general mortality ratio) Pretax excess claims ($ bil.) Posttax excess claims ($ bil.)
Hypothetical extreme mortality scenario Based on 1918-1919 Spanish flu pandemic (25% lower than historic event) 4.9 71 3.5 66.2 52.3
Hypothetical moderate mortality scenario Based on 1957 Asian flu pandemic 0.7 62 0.4 8.3 6.6
*Population excess deaths per 1,000 based on U.S. CDC reports on U.S. deaths from pandemics. We haircut the actual population deaths from the 1918 pandemic by 25% for our extreme mortality scenario.

Modified 1918 pandemic for extreme scenario.  In terms of extreme mortality stress, we looked to the 1918 Spanish flu (H1N1) event. This is considered to be the deadliest pandemic of the 20th century. Related deaths are estimated to be over 40 million worldwide, including about 675,000 in the U.S. The world population at that time was estimated to be about 1.9 billion and the U.S. population about 103 million.

The H1N1 virus has been synthesized since then, but there weren't influenza vaccines back in 1918. Antibiotics needed to treat any secondary bacterial morbidity were also not easily available. We think current health care facilities are better equipped than in 1918 to reduce the mortality of such a pandemic. For these reasons, we haircut the actual deaths from the 1918 event (6.5 excess deaths per 1,000) by about 25% and used 4.9 excess deaths per 1,000 for the general population in our extreme stress scenario.

1957 pandemic for moderate scenario.  As for our moderate stress, we looked at the 1957 Asian flu (H2N2). This was also a global pandemic, with about 1.1 million deaths worldwide and 116,000 in the U.S. The 1957 pandemic was far less severe than the 1918 contagion, but it still had a larger impact than a "normal" annual seasonal flu in the U.S. We used the excess deaths from 1957 pandemic (0.7 excess deaths per 1,000) for the general population in our moderate stress scenario.

Table 2

Impact On U.S. Population From Past Pandemics And Flu Seasons
Pandemic* Approximate U.S. deaths Excess deaths per 1,000
H1N1 Spanish flu (1917-18) 675,000 6.5
H2N2 Asian flu (1957-58) 116,000 0.7
H3N2 Hong Kong flu (1968-69) 100,000 0.5
Avg. seasonal flu 37,875 0.1
*We didn't include the SARS epidemic since there weren't any reported deaths in the U.S.; average seasonal flu deaths are an average of reported deaths 2011-2019; deaths per 1,000 calculated as (reported U.S. deaths from the pandemic/U.S. population)* 1,000. Source: U.S. Centers for Disease Control.

General population-to-insured population.  Not all people have life insurance policies. The demographics of individuals with a life insurance policy can differ from the overall population. Therefore, we needed to quantify how much of the general population's excess deaths per 1,000 would relate to the insured population.

The Society of Actuaries (SOA) undertook a study in 2007 (Delphi Method) to estimate the expected impact of a pandemic on the insured population. We used the median result of this study to identify what proportion of the general population excess deaths per 1,000 can be translated to insured lives. We applied 62% for the moderate scenario and 71% for the extreme scenario. As a result, our key inputs were 3.5 excess (insured) deaths per 1,000 for the extreme scenario and 0.43 excess (insured) deaths per 1,000 for the moderate scenario (see table 1).

Calculating excess mortality claims.  By multiplying the excess insured deaths with the total life insurance policies outstanding, we get to the total number of excess insured deaths. We then multiplied the total insured deaths with average face value per policy, net of reinsurance, (assumed to be $75,000 per policy) to arrive at the excess mortality claims. This resulted in pretax excess claims of $66 billion for our extreme scenario and $8 billion for our moderate scenario.

Aftertax excess mortality claims.  For calculating aftertax excess claims, we used a 21% corporate tax rate. We realize the effective tax rate can vary by insurer, but this rate is a reasonable assumption for this test. Aftertax excess claims were $52 billion for the extreme scenario and $7 billion for the moderate scenario.

Other Considerations For The Stress Test

Age distribution.  We assumed a flat mortality distribution for this stress test. However, pandemics could affect various age groups differently.

Generally for a seasonal flu in the U.S., the most-affected people are the very young and very old, with limited mortality in the middle-age group. This is referred to as "U-shaped" mortality, which was also the case for the 1957 pandemic. But epidemiologists have noted that the Spanish flu was quite unique in that there was a spike in 20-40 year age group. This is often referred to as the "W-shaped" mortality curve. We have no way of knowing how exactly the next pandemic could affect different ages, and an age distribution of the insured population wasn't easily available. Therefore, we maintained a flat excess mortality distribution for our study.

Longevity offset.  We did not mitigate the mortality stress results by any reserve releases or offsets from insurers' longevity business. It's possible that, in an extreme mortality scenario, insurers would report better results in their longevity business. Although we didn't quantify the longevity offset, we recognize the benefits of having a diversified risk profile. As the industry boosts its longevity exposure through sales of retail and institution retirement products, an extreme mortality event could see some offsets from that growing line.

Mortality Risk Remains A Stable Business Line For Life Insurers

Despite some recent stagnation in improved longevity, the U.S. population has seen a long-term trend of longevity gains (see chart 2). Comparing the current life expectancy (at birth) with the pre-1918 and pre-1957 pandemics provide a stark comparison. In 2018, U.S. life expectancy was 78.7, which is extremely favorable to 48.4 in 1917 and 69.8 in 1956.

This long-term improving trend is favorable for mortality risk, and U.S. life insurers have seen good mortality results. We also look at insurers' risk management frameworks and the use of reinsurance to offset the potential impact of higher-than-expected morality events. There have been blips, where mortality trends may see isolated spikes in a certain quarter for a particular insurer, but overall we view this business as stable.

Chart 2

image

Stress Testing In Stressful Times

As credit ratings analysts, we often undertake stress-testing exercises to better comprehend the financial and business impacts of an expected or hypothetical events. Such testing results provide us and the users of our ratings with better insights into the credit quality of the sector. But there perhaps isn't a more-morbid stress testing exercise than one looking at extreme mortality. The spread of an actual pandemic has personal impacts far beyond these stressed excess mortality claims. We hope the mortality scenarios used in this stress test remain purely hypothetical.

Related Research

  • Coronavirus To Inflict A Large, Temporary Blow To China's Economy, Feb. 6, 2020
  • Ten Things You Need To Know About U.S. Insurers' Long-Term Care Business, Jan. 23, 2020

This report does not constitute a rating action.

Primary Credit Analyst:Deep Banerjee, Centennial (1) 212-438-5646;
shiladitya.banerjee@spglobal.com
Secondary Contacts:Peggy H Poon, CFA, New York (1) 212-438-8617;
peggy.poon@spglobal.com
Tracy Dolin, New York (1) 212-438-1325;
tracy.dolin@spglobal.com
Carmi Margalit, CFA, New York (1) 212-438-2281;
carmi.margalit@spglobal.com
Neil R Stein, New York (1) 212-438-5906;
neil.stein@spglobal.com

No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of Standard & Poor’s Financial Services LLC or its affiliates (collectively, S&P). The Content shall not be used for any unlawful or unauthorized purposes. S&P and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an “as is” basis. S&P PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P does not act as a fiduciary or an investment advisor except where registered as such. While S&P has obtained information from sources it believes to be reliable, S&P does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives. Rating-related publications may be published for a variety of reasons that are not necessarily dependent on action by rating committees, including, but not limited to, the publication of a periodic update on a credit rating and related analyses.

To the extent that regulatory authorities allow a rating agency to acknowledge in one jurisdiction a rating issued in another jurisdiction for certain regulatory purposes, S&P reserves the right to assign, withdraw or suspend such acknowledgment at any time and in its sole discretion. S&P Parties disclaim any duty whatsoever arising out of the assignment, withdrawal or suspension of an acknowledgment as well as any liability for any damage alleged to have been suffered on account thereof.

S&P keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain business units of S&P may have information that is not available to other S&P business units. S&P has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P reserves the right to disseminate its opinions and analyses. S&P's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.ratingsdirect.com and www.globalcreditportal.com (subscription), and may be distributed through other means, including via S&P publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.

Any Passwords/user IDs issued by S&P to users are single user-dedicated and may ONLY be used by the individual to whom they have been assigned. No sharing of passwords/user IDs and no simultaneous access via the same password/user ID is permitted. To reprint, translate, or use the data or information other than as provided herein, contact S&P Global Ratings, Client Services, 55 Water Street, New York, NY 10041; (1) 212-438-7280 or by e-mail to: research_request@spglobal.com.

 

Create a free account to unlock the article.

Gain access to exclusive research, events and more.

Already have an account?    Sign in